ResMed Inc. RMD
$218.27
-$1.31-0.60%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.98% | 9.23% | 13.92% | 11.94% | 29.93% |
| Total Depreciation and Amortization | -28.13% | 37.14% | 13.01% | 8.50% | 41.58% |
| Total Amortization of Deferred Charges | -0.87% | 2.67% | -0.16% | -0.91% | -6.24% |
| Total Other Non-Cash Items | -6.04% | 19.62% | 17.92% | 30.13% | -27.73% |
| Change in Net Operating Assets | -114.24% | -61.32% | -23.85% | 142.52% | 2.86% |
| Cash from Operations | -15.62% | -4.24% | 10.08% | 40.48% | 22.42% |
| Capital Expenditure | -67.16% | -61.83% | -38.24% | -140.84% | -22.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -134.76% | -- | 100.00% | -- | -603.55% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -120.32% | 104.63% | -45.68% | -145.49% | 1,935.84% |
| Cash from Investing | -186.92% | -82.56% | -38.84% | -2,550.05% | -187.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | 0.00% | -- | 98.33% |
| Issuance of Common Stock | -2.79% | -17.69% | 9.97% | -2.12% | 8.89% |
| Repurchase of Common Stock | -99.20% | -132.70% | -112.95% | -199.10% | -99.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.24% | -12.27% | -12.73% | -12.66% | -9.97% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.58% | -77.16% | -75.11% | -52.75% | 58.33% |
| Foreign Exchange rate Adjustments | -97.46% | -67.58% | 109.60% | -100.64% | 27,475.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.12% | -40.73% | -65.24% | -7.24% | 61,261.20% |